Literature DB >> 14710700

Cognitive impairment in the intensive care unit.

Margaret A Pisani1, Lynn McNicoll, Sharon K Inouye.   

Abstract

Delirium is a frequent complication in older patients in the ICU and often persists beyond their ICU stay. Delirium in older persons in the ICU is a dynamic and complex process. There is a high prevalence of pre-existing cognitive impairment in patients who are admitted to the medical ICU. This pre-existing cognitive impairment is an important predisposing risk factor for the development of delirium during and after the ICU stay. Given the high rates of delirium in the ICU that range from 50% to 80% (see references [27, 28, 34]), future studies are urgently needed to examine risk factors for delirium in the ICU setting, such as examining the impact of psychoactive medication use on delirium rates and persistence in the ICU setting. Moreover, studies that examine the impact of delirium prevention in the ICU on rates of delirium, duration and persistence of delirium, and long-term cognitive and functional outcomes post-ICU stay are greatly needed.

Entities:  

Mesh:

Year:  2003        PMID: 14710700     DOI: 10.1016/s0272-5231(03)00092-3

Source DB:  PubMed          Journal:  Clin Chest Med        ISSN: 0272-5231            Impact factor:   2.878


  27 in total

1.  Reply to the comment by Skrobik et al.

Authors:  Sophia de Rooij; Evert de Jonge
Journal:  Intensive Care Med       Date:  2004-05-25       Impact factor: 17.440

2.  Ethical challenges involved in obtaining consent for research from patients hospitalized in the intensive care unit.

Authors:  Fiona Ecarnot; Jean-Pierre Quenot; Guillaume Besch; Gaël Piton
Journal:  Ann Transl Med       Date:  2017-12

3.  A psychometric evaluation of the Family Decision-Making Self-Efficacy Scale among surrogate decision-makers of the critically ill.

Authors:  Grant A Pignatiello; Elliane Irani; Sadia Tahir; Emily Tsivitse; Ronald L Hickman
Journal:  Palliat Support Care       Date:  2020-10

4.  Identification of Patients With High Mortality Risk and Prediction of Outcomes in Delirium by Bispectral EEG.

Authors:  Gen Shinozaki; Nicholas L Bormann; Aubrey C Chan; Kasra Zarei; Nicholas A Sparr; Mason J Klisares; Sydney S Jellison; Jonathan T Heinzman; Elijah B Dahlstrom; Gabrielle N Duncan; Lindsey N Gaul; Robert J Wanzek; Ellyn M Cramer; Charlotte G Wimmel; Sayeh Sabbagh; Kumi Yuki; Michelle T Weckmann; Thoru Yamada; Matthew D Karam; Nicolas O Noiseux; Eri Shinozaki; Hyunkeun R Cho; Sangil Lee; John W Cromwell
Journal:  J Clin Psychiatry       Date:  2019-09-03       Impact factor: 4.384

Review 5.  Haloperidol dosing strategies in the treatment of delirium in the critically ill.

Authors:  Erica H Z Wang; Vincent H Mabasa; Gabriel W Loh; Mary H H Ensom
Journal:  Neurocrit Care       Date:  2012-02       Impact factor: 3.210

Review 6.  Delirium assessment in the critically ill.

Authors:  John W Devlin; Jeffrey J Fong; Gilles L Fraser; Richard R Riker
Journal:  Intensive Care Med       Date:  2007-03-31       Impact factor: 17.440

7.  Comparing cognitive load levels among family members of the critically ill exposed to electronic decision aids.

Authors:  Grant A Pignatiello; Barbara Daly; Heath Demaree; Shirley Moore; Ronald L Hickman
Journal:  Appl Nurs Res       Date:  2019-09-03       Impact factor: 2.257

Review 8.  Delirium in elderly adults: diagnosis, prevention and treatment.

Authors:  Tamara G Fong; Samir R Tulebaev; Sharon K Inouye
Journal:  Nat Rev Neurol       Date:  2009-04       Impact factor: 42.937

Review 9.  Detection and management of pre-existing cognitive impairment and associated behavioral symptoms in the Intensive Care Unit.

Authors:  Hochang B Lee; Candyce J DeLoatch; SeongJin Cho; Paul Rosenberg; Simon C Mears; Frederick E Sieber
Journal:  Crit Care Clin       Date:  2008-10       Impact factor: 3.598

Review 10.  Pharmacologic management of the older woman undergoing surgery.

Authors:  Seine Chiang; Kimberly A Gerten; Evelyn Granieri; Holly E Richter
Journal:  Womens Health (Lond)       Date:  2009-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.